![]() ![]() ![]() ![]() Original Assignee Atea Pharmaceuticals Inc Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) ( en Inventor Jean-Pierre Sommadossi Adel Moussa Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US15/063,461 Other versions US20160257706A1 Google Patents β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatmentĭownload PDF Info Publication number US9828410B2 US9828410B2 US15/063,461 US201615063461A US9828410B2 US 9828410 B2 US9828410 B2 US 9828410B2 US 201615063461 A US201615063461 A US 201615063461A US 9828410 B2 US9828410 B2 US 9828410B2 Authority US United States Prior art keywords alkyl compound methyl fluoro hydrogen Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US9828410B2 - β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment US9828410B2 - β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |